Ad-hoc | 22 July 2024 17:49 Epigenomics AG / Schlagwort(e): Halbjahresergebnis Epigenomics AG: Vorläufiges Halbjahresergebnis zum 30. Juni 2024 22.07.2024 / 17:49 CET/CEST Veröffentlichung einer Insiderinformation nach Artikel 17 der Verordnung (EU) Nr. 596/2014, übermittelt durch EQS News – ein Service der EQS Group AG. Für den Inhalt der Mitteilung ist der Emittent / Herausgeber […]
Category: Insider Information
30. October 2023
Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024
Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024 30-Oct-2023 / 15:49 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is solely responsible for the […]
10. October 2023
Epigenomics AG: Closing of Agreement on the Acquisition of Almost All Assets and Adjustment of Guidance for 2023
Epigenomics AG / Key word(s): Contract/DisposalEpigenomics AG: Closing of Agreement on the Acquisition of Almost All Assets and Adjustment of Guidance for 2023 10-Oct-2023 / 20:56 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is […]
11. September 2023
Epigenomics AG: Approval by the Extraordinary General Meeting of the acquisition of almost all assets and corresponding change of the statutory purpose of the Company
Epigenomics AG / Key word(s): AGM/EGMEpigenomics AG: Approval by the Extraordinary General Meeting of the acquisition of almost all assets and corresponding change of the statutory purpose of the Company 11-Sep-2023 / 15:54 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a […]
02. August 2023
Epigenomics AG: Capital reduction planned at a ratio of 5 : 1
Epigenomics AG / Key word(s): Corporate Action/MiscellaneousEpigenomics AG: Capital reduction planned at a ratio of 5 : 1 02-Aug-2023 / 10:36 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is solely responsible for the content […]
24. July 2023
Epigenomics AG: Agreement on the Acquisition of Almost All Assets
Epigenomics AG / Key word(s): Strategic Company Decision/ContractEpigenomics AG: Agreement on the Acquisition of Almost All Assets 24-Jul-2023 / 18:29 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is solely responsible for the content of […]